Bill Haney gives up CEO post at Sky­hawk, be­comes chair­man; Bay­er parts ways with head of biotech

Bill Haney has helped Sky­hawk Ther­a­peu­tics stand out in the wave of biotechs look­ing to drug RNA, tak­ing over from fel­low co-founder Kath­leen Mc­Carthy …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.